AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.3 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer

Yakun Wua, Hui Lyua, Congcong Tana, Margaret E. Larsena, Shou-Ching Tangb, Shile Huangc, Bolin Liua( )
Departments of Interdisciplinary Oncology and Genetics, LSU LCMC Health Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
Department of Medicine, LSU LCMC Health Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71103, USA

Peer review under the responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Wu Y, Lyu H, Tan C, et al. Synergistic anti-tumor activity of ciclopirox olamine and metformin in triple-negative breast cancer. Genes & Diseases, 2026, 13(2). https://doi.org/10.1016/j.gendis.2025.101538

360

Views

1

Downloads

2

Crossref

4

Web of Science

3

Scopus

0

CSCD

Received: 04 October 2024
Published: 22 January 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).